Products

BOC-D-Asparagine

    • Product Name: BOC-D-Asparagine
    • Factroy Site: Yudu County, Ganzhou, Jiangxi, China
    • Price Inquiry: admin@ascent-chem.com
    • Manufacturer: Ascent Petrochem Holdings Co., Limited
    • CONTACT NOW
    Specifications
    HS Code 803120
    Product Name BOC-D-Asparagine
    Chemical Name N-(tert-Butoxycarbonyl)-D-asparagine
    Iupac Name (2R)-4-amino-2-[(tert-butoxycarbonyl)amino]-4-oxobutanoic acid
    Cas Number 75647-01-7
    Molecular Formula C9H16N2O5
    Molecular Weight 232.23 g/mol
    Appearance White to off-white crystalline powder
    Purity ≥98% (HPLC)
    Melting Point 170-175 °C (with decomposition)
    Optical Rotation [α]20/D = +6.5° (c=1, DMF)
    Solubility Soluble in DMF, DMSO, and methanol; sparingly soluble in water
    Storage Conditions Store at 2-8 °C for short-term, -20 °C for long-term; protect from light and moisture

    As an accredited BOC-D-Asparagine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing BOC-D-Asparagine is supplied as a white crystalline powder in a sealed glass vial, typically containing 5 grams per unit.
    Container Loading (20′ FCL) Standard 20′ FCL container loading of BOC-D-Asparagine chemical: 25kg fiber drums, palletized, stretch-wrapped, securely dunnaged for sea transport.
    Shipping BOC-D-Asparagine ships as a non-hazardous, moisture-sensitive chemical. It should be packaged in a sealed, light-protected container and transported at ambient temperature in a dry environment. Avoid exposure to excess heat, humidity, or prolonged sunlight to maintain purity. Standard handling precautions apply, with suitable labeling for laboratory chemical transport.
    Storage Store BOC-D-Asparagine in a tightly sealed container away from moisture, light, and heat. For long-term stability, keep it refrigerated, ideally at or below -20°C. Avoid repeated freeze-thaw cycles, and allow the vial to warm to room temperature before opening under dry, inert conditions to prevent condensation and decomposition.
    Shelf Life Store at -20°C, desiccated and protected from light; shelf life is typically 2–3 years when handled properly.
    Application of BOC-D-Asparagine

    In multi-kilogram solid-phase peptide synthesis campaigns employing tert-butyloxycarbonyl/benzyl protection, BOC-D-Asparagine is introduced as an Nα-protected D-asparagine monomer whose side-chain carboxamide remains unprotected. On production-scale SPPS equipment, typically a 50 L PTFE-lined agitated pressure vessel with jacket temperature control of ±1°C, the monomer is dissolved in DMF or NMP and activated with HBTU/DIEA or DIC/HOBt immediately before coupling. The addition ratio is adjusted against free amine resin loading: at 0.30–0.50 mmol/g, 3.5–4.0 equivalents of BOC-D-Asparagine are used; at 0.50–0.70 mmol/g, 2.5–3.5 equivalents are used. Coupling reagent equivalents are set 0.2–0.3 below monomer equivalents, and DIEA is maintained at 4.0–6.0 equivalents relative to BOC-D-Asparagine to avoid base-catalyzed carboxamide dehydration. Coupling proceeds at 20–25°C for 45–90 min with recirculation. Batch-to-batch variance observed on 50 L reactors indicates that preactivation longer than 90 s at 25°C increases β-cyanoalanine-related impurity detected as a -17 Da mass shift in LC-MS. TFA-mediated Nα-Boc deprotection uses 40–50% TFA in DCM with 1.0–2.0% anisole as scavenger for 20–30 min. Final resin cleavage is performed with HF/anisole/dimethyl sulfide at -5 to 0°C for 45–60 min, followed by ether precipitation. Residual DMF is controlled to 880 ppm and DCM to 600 ppm under ICH Q3C Class 2 limits. Incoming material control follows 21 CFR 211.84 and ICH Q7 Chapter 7. The terminal product types are therapeutic peptide APIs and generic peptide active substances in which D-Asn is incorporated to reduce enzymatic degradation at the target sequence position.

    Production-scale coupling parameter matrix for BOC-D-Asparagine in Boc SPPS
    Resin loadingBOC-D-Asparagine equivalentsHBTU equivalentsDIEA equivalentsCoupling temperature
    0.30–0.50 mmol/g3.5–4.03.3–3.84.0–6.020–22°C
    0.50–0.70 mmol/g2.5–3.52.4–3.34.0–6.022–25°C
    Incoming control matrix for BOC-D-Asparagine in GMP peptide API manufacture
    AttributeAnalytical methodDownstream control purpose
    Chiral identityPh. Eur. 2.2.7 / USP <781>Confirms D-configuration before resin loading
    Water contentUSP <921> / Ph. Eur. 2.5.12Controls hydrolysis of activated intermediate
    Residual solventsUSP <467> / Ph. Eur. 5.4Regulates DMF, DCM, and NMP carryover into peptide API
    Related substancesPh. Eur. 2.2.29Limits L-Asn and β-cyanoalanine impurities
    AssayHPLC area percentageCorrects coupling stoichiometry

    Why Is BOC-D-Asparagine Used in Solution-Phase Fragment Condensation Routes?

    Solution-phase fragment condensation is selected when a peptide sequence contains a single D-Asn residue in a short protected fragment and when avoiding piperidine-induced aspartimide side products is operationally valuable. BOC-D-Asparagine is converted to an active ester or mixed anhydride; because the N-terminal BOC group is orthogonal to benzyl and tert-butyl side-chain protections, the carboxamide side chain of asparagine may remain unprotected. The protected amino acid is coupled at 1.00–1.15 equivalents relative to the amino terminal of the C-terminal fragment, with EDC/HOBt at 1.05–1.20 equivalents and DIEA at 2.0–2.5 equivalents in DCM/THF at -10 to 5°C. The low-temperature activation window suppresses nitrile formation from the carboxamide, which is the principal process impurity. Batch records from 20 L jacketed reactors indicate that exceeding 5°C during mixed anhydride formation increases β-cyanoalanine-related impurity by measurable levels. After coupling, the reaction mass is quenched with aqueous citric acid, washed with sodium bicarbonate, dried over magnesium sulfate, and crystallized from ethyl acetate/n-heptane. The product is used as a protected fragment intermediate for subsequent segment condensation. Compliance with ICH Q7 Chapter 7 and Chapter 8, 21 CFR 211.84, and ICH Q3C governs incoming material control and residual solvent limits. Terminal product types include protected linear peptide fragments and final peptide APIs containing D-Asn in cases where solution-phase fragment coupling is part of the registered route.

    Manufacture of pharmacopeial peptide impurity standards and reference materials that contain D-Asn requires an enantiomerically defined starting material for deletion, insertion, and epimer variants of peptide APIs. BOC-D-Asparagine is coupled in manual or automated solid-phase synthesis on 2-chlorotrityl or Wang resin at 1.0–1.2 equivalents relative to free amine, using DIC/HOBt in DMF at 25±2°C for 30–45 min. After assembly, cleavage with TFA/triisopropylsilane/water at 95:2.5:2.5 yields the crude reference peptide, which is purified by preparative HPLC and lyophilized. Characterization follows ISO/IEC 17025:2017 for analytical data, and reference material production follows ISO 17034:2016. Analytical test methods include Ph. Eur. 2.2.43 for mass spectrometry and USP <621> for chromatographic purity. Terminal product types are lyophilized peptide impurity standards and system suitability standards used in HPLC and LC-MS method validation.

    Cosmeceutical Short-Chain D-Asn Peptide Synthesis and Protease Resistance Requirements

    Short-chain cosmeceutical peptides containing D-Asn are synthesized using standard Fmoc/tBu solid-phase protocols when BOC-D-Asparagine is introduced as the N-terminal residue; the BOC group is removed by TFA after coupling, and the free N-terminal amine is then acetylated or palmitoylated. The addition ratio of BOC-D-Asparagine during N-terminal coupling is 2.0–3.0 equivalents relative to resin loading, with HCTU/DIPEA in DMF at 20–25°C for 30–45 min. The downstream process uses preloaded Wang or 2-chlorotrityl resin, Fmoc-deprotection with 20% piperidine in DMF, final TFA/triisopropylsilane/water cleavage, precipitation in cold diethyl ether, and preparative HPLC. The D-configuration of asparagine is selected to reduce aminopeptidase and endopeptidase degradation in topical formulations, which is a formulation-driven stability criterion rather than a pharmacological claim. Compliance for the peptide concentrate is assessed according to EC 1223/2009 Article 10 safety assessment and, where applicable, ISO 16128; residual solvent testing uses USP <467>. Published quantitative migration data for BOC-D-Asparagine-derived peptides in finished cosmetic formulations is limited, so the relevant control point is the purified peptide concentrate before incorporation. Terminal product types include cosmetic peptide concentrates and topical formulations in which the peptide is incorporated at low parts-per-million levels.

    If Residual Epimerization Must Remain Below 0.10%, D-Asn Reference Peptide Production Parameters Are Tightened

    When D-amino acid containing peptides are produced as enzyme-resistance screening standards or as chiral purity controls, the critical quality attribute is residual L-asparagine at the D-Asn position. BOC-D-Asparagine is incorporated at 1.8–2.5 equivalents relative to resin loading, with DIC/HOBt at 1.8–2.5 equivalents in DMF at 22±2°C; after each coupling, unreacted amine is capped with acetic anhydride/pyridine at 1:1 for 10 min. The downstream process is manual SPPS in fritted polypropylene syringes or automated peptide synthesizers with nitrogen bubbling. Cleavage with TFA/triisopropylsilane/water at 95:2.5:2.5 is followed by ether precipitation and preparative HPLC. Chiral purity is verified by Marfey's reagent derivatization followed by HPLC-UV using USP <621> conditions; mass identity uses Ph. Eur. 2.2.43. Compliance is driven by ISO/IEC 17025:2017 for the analytical certificate and by internal research quality systems; these materials are not for human use. Terminal product types include D-amino acid scan peptide libraries, protease-resistant substrate peptides, and epimer-spiked system suitability controls.

    Because the carboxamide side chain of asparagine can participate in cyclization side reactions under basic conditions, pilot-scale route scouting for cyclic peptide drug candidates containing D-Asn evaluates solution-phase and solid-phase routes side by side. BOC-D-Asparagine is coupled in solution at 1.05–1.25 equivalents relative to the amino component, with T3P or EDC/HOBt and DIEA at 0–5°C, or on solid support at 2.0–3.0 equivalents relative to resin free amine. The downstream process includes linear assembly, side-chain selective deprotection, cyclization, and preparative HPLC. Analytical monitoring for β-cyanoalanine and aspartimide-related impurities is performed by LC-MS using Ph. Eur. 2.2.43 and HPLC using USP <621>. Compliance follows ICH Q11 for development route selection and ICH Q7 when batches are intended for GLP toxicology or Phase 1 supply. Terminal product types are development batches of cyclic peptide drug candidates and peptide intermediate lots for toxicology studies. Published data for this specific configuration is limited in public literature, so route selection relies on internal batch comparison rather than external reference data.

    Free Quote

    Competitive BOC-D-Asparagine prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please contact us at +8615365186327 or mail to admin@ascent-chem.com.

    We will respond to you as soon as possible.

    Tel: +8615365186327

    Email: admin@ascent-chem.com

    Inquiry

    Get Free Quote of Ascent Petrochem Holdings Co., Limited

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    BOC-D-Asparagine, catalogued under CAS 75647-01-7 and identified systematically as N-α-tert-butoxycarbonyl-D-asparagine, is a protected D-amino acid with molecular formula C9H16N2O5 and molecular weight 232.23 g/mol. The commercial form is the anhydrous free acid, not a salt, hydrate, or preactivated ester. Lot-level documentation describes a white to off-white crystalline powder with solubility in dimethylformamide and dimethyl sulfoxide, limited solubility in methanol, and negligible solubility in water. The tert-butoxycarbonyl group blocks the α-amino function during carboxyl activation and coupling, while the side-chain carboxamide remains unprotected; that unprotected amide is analytically convenient but introduces a dehydration risk during certain coupling protocols.

    Release documentation for this building block is centered on chiral identity and residual water rather than only gross purity. Typical acceptance criteria include reversed-phase HPLC purity ≥ 98.5% by area at 215 nm, enantiomeric purity ≥ 99.0% for the D-isomer with L-isomer ≤ 0.5%, water content ≤ 0.5% by coulometric Karl Fischer titration, and residue on ignition ≤ 0.1%. Because the carboxamide side chain is not protected, the product is more polar than Fmoc-D-Asn(Trt)-OH and may require addition of 10–20% dimethylformamide when dissolution in tetrahydrofuran or dichloromethane is attempted at laboratory scale.

    TFA-Mediated Deprotection and Side-Chain Stability in Solid-Phase Assembly

    In BOC/Bzl solid-phase peptide synthesis, the BOC group is removed with 30–50% trifluoroacetic acid in dichloromethane containing 2.0–5.0% water or triisopropylsilane as cation scavenger. Deprotection at 20–25 °C is generally complete within 20–30 min; incomplete cleavage occurs when the TFA concentration falls below 20% or when resin-bed mixing is insufficient, and the residual N-terminal carbamate reduces coupling efficiency in the subsequent cycle. After acid treatment, neutralization with 5% N,N-diisopropylethylamine in dimethylformamide releases the free amine for coupling.

    The unprotected side-chain amide imposes an operational boundary during activation. If BOC-D-Asparagine is preactivated with N,N′-diisopropylcarbodiimide in dimethylformamide without an auxiliary nucleophile, the primary amide can undergo dehydration to the corresponding β-cyanoalanine derivative. The nitrile impurity is observed as a closely eluting peak in C18 HPLC at 215 nm and is difficult to resolve after incorporation. Addition of 1.0–1.2 equivalents of 1-hydroxybenzotriazole or ethyl cyanohydroxyiminoacetate relative to the carboxylic acid suppresses this side reaction. With uronium reagents such as HBTU, preactivation should be kept below 5 min; with DIC/HOBt, preactivation should not exceed 10–15 min. Under these limits, batch syntheses on automated peptide synthesizers with 0.25–2.0 mmol resin loading typically reach Kaiser-negative coupling endpoints in 45–60 min at 20–25 °C.

    ParameterMethod / ReferenceCriterion
    AppearanceVisual inspectionWhite to off-white crystalline powder
    IdentityInfrared spectrophotometryConcordant with reference spectrum; carbonyl absorbance in the 1680–1700 cm-1 region
    PurityRP-HPLC, UV detection at 215 nm98.5% area
    Enantiomeric purityChiral HPLCD-isomer ≥ 99.0%; L-isomer ≤ 0.5%
    Water contentKarl Fischer coulometry, Ph. Eur. 2.5.120.5%
    Residue on ignitionPh. Eur. 2.4.140.1%
    Specific rotation[α]D20, c = 1.0 in methanol+6.0° to +8.0°

    Moisture uptake above relative humidity 60% alters activation stoichiometry by hydrolyzing active ester intermediates; material stored under these conditions should be re-analyzed for water content before use. Long-term storage at 2–8 °C in tightly closed containers under dry nitrogen is specified in supplier handling documents. Residual solvent content is typically controlled by headspace gas chromatography and aligned with ICH Q3C limits for acetone or dichloromethane depending on the crystallization train.

    The free acid is differentiated from activated ester forms such as BOC-D-Asparagine N-hydroxysuccinimide ester or p-nitrophenyl ester. Activated esters eliminate the need for in situ carboxyl activation in solution-phase couplings but are more moisture-sensitive and are usually supplied in smaller unit sizes. The free acid requires coupling reagents but provides longer shelf stability and lower cost per mole in multi-kilogram campaigns. It also differs from BOC-D-Asparagine β-tert-butyl ester or trityl-side-chain forms, which add side-chain protection and increase molecular weight without changing the α-amino protection scheme.

    Chiral distinction is critical because BOC-D-Asparagine is used to insert a D-asparagine residue into sequences that are not accessible from BOC-L-Asparagine. A 0.5% L-enantiomer burden in the protected monomer creates diastereomeric peptides after chain elongation, and these diastereomers are often more difficult to separate by reversed-phase HPLC than enantiomers because hydrophobicity differences are sequence-dependent rather than absolute. Release testing therefore relies on chiral HPLC with macrocyclic glycopeptide or ligand-exchange stationary phases, not on C18 retention alone.

    When Fmoc-D-Asparagine Becomes the Preferred Building Block

    Fmoc-D-Asparagine occupies the parallel position in Fmoc/tBu solid-phase synthesis, but the two derivatives are not interchangeable without altering the entire orthogonal protection strategy. BOC-D-Asparagine is compatible with final cleavage by anhydrous hydrogen fluoride or trifluoromethanesulfonic acid, which is the standard endpoint in BOC/Bzl assembly. Fmoc-D-Asparagine cannot tolerate those strong-acid cleavage conditions because the Fmoc group is removed under basic conditions, typically 20% piperidine in dimethylformamide. Conversely, on a 2-chlorotrityl chloride resin used in Fmoc/tBu synthesis, BOC-D-Asparagine introduces an acid-labile α-amino group that is not orthogonal to side-chain tert-butyl removal, making final acidic treatment ambiguous.

    Process-scale selection between BOC-D-Asparagine and Fmoc-D-Asparagine is often driven by final deprotection infrastructure. Facilities certified for hydrogen fluoride handling or liquid hydrogen fluoride peptide synthesizers commonly use BOC chemistry, while laboratories without hydrogen fluoride containment favor Fmoc/tBu conditions with trifluoroacetic acid cleavage. In BOC SPPS of peptide amides on methylbenzhydrylamine resin, Fmoc-D-Asparagine is not a drop-in substitute because repeated piperidine washes would strip the base-labile Fmoc group during routine neutralization steps.

    Derivativeα-Amino ProtectionCleavage ConditionsSide-Chain AmidePrimary Workflow
    BOC-D-Asparaginetert-Butoxycarbonyl30–50% TFA or hydrogen fluorideUnprotectedBOC/Bzl SPPS; solution phase
    Fmoc-D-Asparagine9-Fluorenylmethoxycarbonyl20% piperidine in DMFUnprotectedFmoc/tBu SPPS
    Fmoc-D-Asparagine(Trt)-OH9-Fluorenylmethoxycarbonyl20% piperidine in DMFTrityl protectedAggregation-prone or dehydration-sensitive sequences
    Z-D-AsparagineBenzyloxycarbonylCatalytic hydrogenation or HBr/acetic acidUnprotectedSolution-phase segment condensation

    The unprotected carboxamide in BOC-D-Asparagine distinguishes it from side-chain protected derivatives used when asparagine residues appear in aggregation-prone domains. Fmoc-D-Asparagine(Trt)-OH carries a trityl group on the side-chain amide and suppresses interchain hydrogen bonding during resin loading; however, the trityl group increases steric demand and can slow coupling. BOC-D-Asparagine avoids that steric penalty but remains vulnerable to nitrile formation when activation is poorly controlled. Analytical monitoring of the nitrile impurity by HPLC at 215 nm is recommended for any new coupling reagent or solvent system before process lock.

    In solution-phase synthesis, BOC-D-Asparagine is typically coupled via a mixed anhydride or active ester generated in situ. With isobutyl chloroformate and N-methylmorpholine in tetrahydrofuran at −10 °C to 0 °C, the unprotected amide is generally stable; warming above 15 °C during activation increases side-product formation. Batch records from development campaigns note that water contamination above 0.5% in dimethylformamide lowers active ester concentration and leads to incomplete couplings when only 1.0 equivalent of the acid is charged. Production-scale corrections include pre-drying of dimethylformamide over activated molecular sieves and adjusting the acid-to-reagent ratio to 1.0:1.05 for moisture-scavenged systems.

    Published data for the exact nitrile impurity threshold in every coupling system is limited; the values reported above are representative development-batch observations rather than universal kinetic constants. Lot-to-lot variability in residual solvent and water content makes pre-use drying and chiral HPLC verification standard practice in GMP peptide manufacturing. Because BOC-D-Asparagine lacks a strong chromophore above 250 nm, UV detection for purity is performed at 215 nm, where mobile-phase baseline drift and trifluoroacetic acid absorbance require careful gradient blank subtraction.

    The product is supplied as a crystalline solid in high-density polyethylene bottles with desiccant in unit sizes from 5 g to 25 kg. For multi-kilogram lots, drum liners are purged with nitrogen, and analytical retain samples are held under refrigerated conditions for traceability. Unlike resin-bound D-asparagine derivatives or preloaded cartridges, this free acid requires manual dissolution and activation, which is preferred when the same building block is used across multiple peptide sequences or when activation conditions must be varied for difficult couplings.

    In peptide therapeutics where D-asparagine replaces L-asparagine to reduce proteolytic susceptibility, the BOC-protected monomer is incorporated into the growing chain under the same coupling protocols used for BOC-L-amino acids, provided the nitrile-suppression measures are applied. The resulting D-configuration alters backbone geometry and is typically monitored by circular dichroism after cleavage rather than by amino acid analysis alone, because acid hydrolysis during amino acid analysis can racemize asparagine residues and obscure the original stereochemical composition.

    Top